MDDAX | VIVIX | MDDAX / VIVIX | |
Total Expense Ratio | 1.14 | 0.04 | 2,850% |
Annual Report Gross Expense Ratio | 1.14 | 0.04 | 2,850% |
Fund Existence | 20 years | 27 years | - |
Gain YTD | -6.067 | -7.289 | 83% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 303M | 195B | 0% |
Annual Yield % from dividends | 1.39 | 2.27 | 61% |
Returns for 1 year | -26.97 | -1.55 | 1,742% |
Returns for 3 years | -27.07 | 6.83 | -396% |
Returns for 5 years | 19.96 | 82.54 | 24% |
Returns for 10 years | -29.10 | 87.57 | -33% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
DRCVX | 4.07 | -0.06 | -1.45% |
Comstock Capital Value A | |||
OPTFX | 66.05 | -4.44 | -6.30% |
Invesco Discovery Large Cap A | |||
ACVRX | 8.75 | -0.62 | -6.62% |
American Century International Val R | |||
ADNYX | 11.51 | -0.88 | -7.10% |
American Beacon ARK Transfmt Innov Y | |||
LMGCX | 11.01 | -0.85 | -7.17% |
Lord Abbett Growth Opportunities C |